Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead secures European approval for new hepatitis C drug
BioPharma Dive
Mon, 07/11/16 - 11:23 am
Tags:
Gilead Sciences, Europe, hepatitis C, Epclusa
Why This One Biotech is Built Like Apple
Motley Fool
Fri, 07/8/16 - 10:08 am
Tags:
biotech, Gilead Sciences, Apple
Gilead Sciences: ‘This Could Be One of the Strongest Quarters in Some Time’
Barron's
Wed, 07/6/16 - 10:00 pm
Tags:
Gilead Sciences, earnings
Gilead, Pfizer: Giants Continue With US Drug Price Hikes Amid Backlash
Bidness, ETC
Wed, 07/6/16 - 09:50 am
Tags:
Gilead Sciences, Pfizer, drug pricing
Biotech: What's Ahead For The Second Half Of 2016
Seeking Alpha
Tue, 07/5/16 - 09:57 am
Tags:
biotech, AbbVie, Amgen, Allergan, Anacor, Gilead Sciences, Medivation, Pfizer, Sanofi
Gilead hikes price of HIV therapies, other drugs by 7 to 10 percent
Stat
Sat, 07/2/16 - 12:31 pm
Tags:
Gilead Sciences, HIV, drug pricing
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Tags:
Eli Lilly, solanezumab, Alzheimer's disease, Gilead Sciences, hepatitis C, Sovaldi, Harvoni, Epclusa, Sanofi, Regeneron, Praluent
Why Gilead's new hepatitis C drug is a game changer — price and all
Bizjournals.com
Tue, 06/28/16 - 05:37 pm
Tags:
Gilead Sciences, hepatitis C, drug pricing, Epclusa
GSK, GILD, AZN: How Brexit Affects Drug Stocks
Bidness, ETC
Mon, 06/27/16 - 11:08 pm
Tags:
GSK, Gilead Sciences, AstraZeneca, Brexit, UK, Europe
Can Gilead Sciences Rebound in the Second Half of 2016?
Motley Fool
Sat, 06/25/16 - 01:44 pm
Tags:
Gilead Sciences, hepatitis C
Gilead Sciences: What’s Next in Hepatitis C?
Barron's
Fri, 06/24/16 - 09:14 am
Tags:
Gilead Sciences, hepatitis C, sof/vel/GS-9857, sof/vel
What Do Gilead And Martin Shkreli Have In Common?
Seeking Alpha
Wed, 06/22/16 - 06:11 pm
Tags:
Gilead Sciences, Martin Shkreli, Biogen, Jazz Pharmaceuticals, charity
Gilead Sciences, Inc: Where’s The Biotech Giant Headed?
Bidness, ETC
Wed, 06/22/16 - 10:42 am
Tags:
Gilead Sciences, HIV, hepatitis C
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
Motley Fool
Sat, 06/18/16 - 02:24 pm
Tags:
biotech, Amgen, Gilead Sciences, PDL Biopharma
Gilead Sciences, Inc: Uptick in New HCV Scripts Does Not Signal a Good Quarter
Bidness, ETC
Sat, 06/18/16 - 09:18 am
Tags:
Gilead Sciences, Harvoni, Sovaldi, hepatitis C
Gilead Sciences: A ‘Strong Uptick’ in New Hepatitis C Prescriptions
Barron's
Fri, 06/17/16 - 12:16 pm
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Pharm Exec's Top 50 Companies 2016
PharmExec
Thu, 06/16/16 - 03:27 pm
Tags:
Pfizer, Novartis, Roche, Merck, Sanofi, Gilead Sciences, JNJ, GSK
Gilead Sciences Is On The Cusp Of A Breakthrough In NASH
Seeking Alpha
Mon, 06/13/16 - 10:31 am
Tags:
Gilead Sciences, NASH
These 6 Drugmakers Could Be The Next Price War Casualties
Investors.com
Fri, 06/10/16 - 04:20 pm
Tags:
drug pricing, Amgen, Gilead Sciences, Celgene, Biogen, Vertex Pharmaceuticals, Mylan
Will Gilead (GILD) Stock Be Helped by Hepatitis C Drug Patents Case Win?
TheStreet.com
Thu, 06/9/16 - 09:47 am
Tags:
Gilead Sciences, Merck, patents, hepatitis C, Harvoni, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.